TGViewer
生物医学科技前线 生物医学科技前线 @sci_feed · 647 subscribers
Post #4581 112
霸王级减肥药Ozempic等药物取得巨大成果，但面临重大问题
世界卫生组织委托的三项大型综述研究发现，GLP-1类药物，包括特里泽派特（Mounjaro和Zepbound）、赛美格鲁汀（Ozempic和Wegovy）和利拉格鲁汀（Victoza和Saxenda），在肥胖人群中可以带来显著的减重效果。但是，虽然研究结果令人印象深刻…
来源: ScienceDaily ｜ 阅读全文
发布时间: 2026-02-11 23:01 GMT+8（北京时间）
#GLP1类药物 #减肥药 #肥胖 #世界卫生组织
ScienceDaily Blockbuster weight loss drugs like Ozempic deliver big results but face big questions Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people…
Open in Telegram All posts from @sci_feed
More from @sci_feed
  1. Oct 5, 2026The “glue” holding your cells together has a surprising second job Scientists have discove…
  2. Oct 5, 2026The “glue” holding your cells together has a surprising second job Scientists have discove…
  3. Oct 4, 2026This protective enzyme could help stop fatty liver disease from getting worse Scientists h…
  4. Sep 17, 2026This popular fermented food may help flush nanoplastics from the body A kimchi-derived bac…
  5. Sep 17, 2026This popular fermented food may help flush nanoplastics from the body A kimchi-derived bac…
  6. Sep 15, 2026Plague was killing entire families thousands of years before the Black Death Ancient DNA r…
Threads Profile ViewerView any public Threads profile without an account.Open ThreadLook →Writing with AI? Make it sound human.Metric37 rewrites AI drafts so they read naturally. Free AI detector, 1,500 words free.Try Metric37 →